Louisiana 2020 Regular Session

Louisiana Senate Bill SCR31

Introduced
3/31/20  
Introduced
3/31/20  
Refer
5/4/20  

Caption

Requests the Department of Economic Development and the Department of Revenue to develop an incentive package that will make Louisiana the domestic prescription drug manufacturing leader for the United States.

Companion Bills

No companion bills found.

Similar Bills

LA HB616

Provides for disclosure of prescription drug cost information

LA HB436

Requires drug manufacturers to provide information regarding prescription drug prices (EN NO IMPACT See Note)

LA HB384

Creates and provides for a state prescription drug importation program (OR INCREASE SG EX See Note)

LA SR134

Requests evaluation of existing efforts at deterring prescription drug abuse, determination of effectiveness of current efforts, and recommendations on best practices for combating abuse while ensuring access is not restricted for those in need of prescription medications.

LA SB28

Provides relative to veterinarians. (8/1/18)

LA HR114

Requests an evaluation by La. officials of efforts to deter prescription drug abuse and recommendations for best practices to combat such abuse

LA HR181

Urges and requests the Louisiana Department of Health to study the desirability and feasibility of adopting state policy to provide for review of prescription drug prices in the medical assistance program

LA SB59

Provides relative to prescription drug price information. (gov sig)